Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Itri

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|October 8, 1999
Chemotherapy-induced anemia in adults: incidence and treatmentJ E Groopman, L M Itri
Archives of Dermatology|March 1, 1989
Safety of pregnancy after discontinuation of isotretinoinW S Dai, M A Hsu, L M Itri
Lancet (London, England)|September 15, 1984
Failure of isotretinoin in Kaposi's sarcomaJ L Ziegler, P A Volberding, L M Itri
Cancer Treatment Reports|October 1, 1984
Phase II trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumorsE J Gold, G J Bosl, L M Itri
Journal of Medicinal Chemistry|November 1, 1982
Retinoids at the threshold: their biological significance and therapeutic potentialB A Pawson, C W Ehmann, L M Itri, et al.
American Journal of Otolaryngology|July 1, 1988
The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot studyR Bell, W K Hong, L M Itri, et al.
Cancer|December 15, 1986
Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patientsE T Creagan, D L Ahmann, S Frytak, et al.
Cancer Treatment Reports|July 1, 1987
Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomasJ H Edmonson, H J Long, S Frytak, et al.
Lancet (London, England)|September 10, 1983
Isotretinoin in cutaneous T-cell lymphomaR P Warrell, C J Coonley, S J Kempin, et al.
Cancer|February 1, 1987
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analysesE T Creagan, D L Ahmann, S Frytak, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|October 8, 1999
Chemotherapy-induced anemia in adults: incidence and treatmentJ E Groopman, L M Itri
Archives of Dermatology|March 1, 1989
Safety of pregnancy after discontinuation of isotretinoinW S Dai, M A Hsu, L M Itri
Lancet (London, England)|September 15, 1984
Failure of isotretinoin in Kaposi's sarcomaJ L Ziegler, P A Volberding, L M Itri
Cancer Treatment Reports|October 1, 1984
Phase II trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumorsE J Gold, G J Bosl, L M Itri
Journal of Medicinal Chemistry|November 1, 1982
Retinoids at the threshold: their biological significance and therapeutic potentialB A Pawson, C W Ehmann, L M Itri, et al.
American Journal of Otolaryngology|July 1, 1988
The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot studyR Bell, W K Hong, L M Itri, et al.
Cancer|December 15, 1986
Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patientsE T Creagan, D L Ahmann, S Frytak, et al.
Cancer Treatment Reports|July 1, 1987
Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomasJ H Edmonson, H J Long, S Frytak, et al.
Lancet (London, England)|September 10, 1983
Isotretinoin in cutaneous T-cell lymphomaR P Warrell, C J Coonley, S J Kempin, et al.
Cancer|February 1, 1987
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analysesE T Creagan, D L Ahmann, S Frytak, et al.
Pageof 5